thrombocythemia, and primary myelofibrosis: a paradigm of effective collaboration among clinicians, pathologists, and scientists Drs Samuelson, Parker, and Prchal raise several concerns regarding the recently published proposal for the revision of the 2001 World Health Organization (WHO) diagnostic criteria for polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).1 For the record, the particular document has now been formally incorporated, in its entirety, into the upcoming revised 2008 WHO “Blue Book ” on th
European experts were convened to develop a definition of response to treatment in polycythemia vera...
In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducib...
Polycythemia vera (PV) is a clonal Ph-negative myeloproliferative disorder characterized by excessiv...
thrombocythemia, and primary myelofibrosis: a paradigm of effective collaboration among clinicians, ...
Clinical evidence supports the need of changing the diagnostic criteria of the 2008 updated WHO clas...
Item does not contain fulltextThe clinical criteria according to the Polycythemia Vera Study Group (...
Standardized response criteria to interpret and compare clinical trials are needed for approval of n...
The 2016 multiparameter World Health Organization (WHO) classification for Philadelphia-negative mye...
Contains fulltext : 53124.pdf (publisher's version ) (Closed access)The bone marro...
International audienceAims: To evaluate the feasibility of the histopathological diagnosis of prefib...
Polycythemia vera (PV) is a Philadelphia chromosomeâ negative chronic myeloproliferative neoplasm th...
The aim of this review is to critically address the validity and clinical applicability of three maj...
Purpose: The WHO diagnostic criteria underscore the role of bone marrow (BM) morphology in distingui...
European experts were convened to develop a definition of response to treatment in polycythemia vera...
In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducib...
Polycythemia vera (PV) is a clonal Ph-negative myeloproliferative disorder characterized by excessiv...
thrombocythemia, and primary myelofibrosis: a paradigm of effective collaboration among clinicians, ...
Clinical evidence supports the need of changing the diagnostic criteria of the 2008 updated WHO clas...
Item does not contain fulltextThe clinical criteria according to the Polycythemia Vera Study Group (...
Standardized response criteria to interpret and compare clinical trials are needed for approval of n...
The 2016 multiparameter World Health Organization (WHO) classification for Philadelphia-negative mye...
Contains fulltext : 53124.pdf (publisher's version ) (Closed access)The bone marro...
International audienceAims: To evaluate the feasibility of the histopathological diagnosis of prefib...
Polycythemia vera (PV) is a Philadelphia chromosomeâ negative chronic myeloproliferative neoplasm th...
The aim of this review is to critically address the validity and clinical applicability of three maj...
Purpose: The WHO diagnostic criteria underscore the role of bone marrow (BM) morphology in distingui...
European experts were convened to develop a definition of response to treatment in polycythemia vera...
In myeloproliferative neoplasms (MPNs), controversy persists regarding the usefulness and reproducib...
Polycythemia vera (PV) is a clonal Ph-negative myeloproliferative disorder characterized by excessiv...